A research study of the daily chart of EGTX, which can be found at https://query1.finance.yahoo.com/v8/finance/chart/EGTX.ST, shows that as of September 4, the price was 7.65. The last complete price was 7.70, which is higher than the 50-day Simple Moving Average of 6.75 and the 20-day average of 8.75, with an 8.757% increase. However, using these indicators together to decide when to buy or sell does not work when looking back at past data. The Average True Range, a measure of price volatility, is 14.355714, and the average daily range over 20 days is 0.318, suggesting a possible stop-loss at 7.34429 and a target price of 8.23357, which is slightly above the 20-day high of 8.20. The potential return on investment, considering costs, is 1.170, which is less than the minimum required of 1.5. The median volume of 678,731 indicates that the stock has been actively traded in the past, but this does not necessarily mean that it can be easily bought or sold now. Based on this analysis, no recommendation is made to buy or sell at a specific price. Adjusting the stop-loss or target price to improve the return on investment would require changing the predefined rules or exceeding the allowed price range, so this option is rejected. The largest historical overnight loss of 26.8382% on May 24, 2023, highlights the risk of significant price gaps, but it does not prove how often such shocks occur due to FDA announcements. The return and volatility calculations are based on observed trading days, not calendar days.
A news scan found the note about a frozen long-only trend diagnostic test for EGTX that failed its holdout test, which is not a test of a PDUFA, or US Food and Drug Administration, backtest. The test used Yahoo's adjusted open, high, low, and close data from https://query1.finance.yahoo.com/v8/finance/chart/EGTX.ST, with a training period from September 2021 to December 2024 and a holdout period from January 2025 to September 4, 2026. The test entered a trade at the next open if the prior close was greater than the 50-period simple moving average, or SMA, which is a calculation of the average price of a stock over a certain period, and the 20-row return was greater than 0. The test set a stop loss at 1 average true range, or ATR, which is a measure of volatility, and a target at 1.5 ATR. The test exited trades within 10 sessions and did not allow same-bar reentry. The test also filled gap stops at the open, capped targets, and stopped at both barriers first. The test included fees of 10 basis points, or 0.1%, plus slippage of 25 basis points, or 0.25%, on each side, and stressed slippage at 50 basis points, or 0.5%. The test used vectorbt, a backtesting library, with a long-only direction and two timestamp slots per day, allowing for same-day exits. The test reconciled compounded trade and portfolio returns to 1e-8, which is a very small number. The test calculated close-marked drawdown, which is a measure of the peak-to-trough decline in value, approximately, excluding 15-minute paths, foreign exchange, and minimum foreign commissions. The test results for the training period were 87.6467% return, 91.0246% drawdown, 89 trades, and 33.7079% win rate. The holdout results were below these figures, with a 10000 iid trade bootstrap mean confidence interval of -2.77568% to 0.80464%. The test found weak regime dependence, which refers to the relationship between the test results and the underlying market conditions. The test swept SMA 30, 50, and 70, with hold periods of 5, 10, and 15, and two cost scenarios, resulting in 18 holdout variants, all of which were negative, ranging from -75.9915% to -43.2968%. The test did not adopt any selection. The test premises, or assumptions, were that actual long trends lose, and there is no historical cohort of US FDA data and no venue command-line interface, or CLI, with 0 bars. The conclusion of the test was to reject this rule, as it cannot be inferred that all FDA strategies lose or that generic trend wins are applicable to dated trades. The full reproduction of the research is available in the research/test.py file, and the results and trades files are saved locally, with journal chunks forthcoming.
A fund manager analyzed the stock PATH. The manager considered three premises: a jump in the stock's price may or may not happen again, but it can signal a change in volatility, a useful alternative to the current method must improve future forecasts, and forecast accuracy is not the same as the expected value of traded options. The manager used a formula to calculate the stock's price changes, where r is the log of the current price divided by the previous price, g is the log of the current option price divided by the previous stock price, and i is the log of the current stock price divided by the current option price. The manager clipped g at +/-3 times the prior 60-day gap root mean square and reconstructed r. The manager then calculated forecasts using a formula that combines the mean of the squared price changes and an exponentially weighted moving average. The manager used data from April 21, 2021, to September 4, 2026, and found that the current sigma base is 87.80%, the clipped sigma base is 71.85%, and the realized volatility over 60 days is 68.75%. The manager trained the model on data from 2022 to 2025 and tested it on data from 2026. The results showed that the clipped model performed better on the training data, but not on the holdout data. The manager also found that the clipped model performed better on negative events, but the results were sensitive to influential events. The manager concluded that historic downward shocks often decay, but there is no evidence that universal clipping is superior. The manager also found that the relationship between log future variance and log base/jump is sparse and not suitable for estimating a causal jump premium. The manager recorded all forecast rows, events, and inputs as observations and noted that the prior remains unresolved.
The QREV90804 ETF economics report discusses country exposure and valuation. The report starts with an issuer snapshot of EWJ, which is recorded in observation12340. This snapshot shows differences in share price, net asset value (NAV), non-fair-valued NAV, and foreign security and foreign exchange (FX) clocks. However, these differences do not necessarily mean that a profitable trade, known as executable arbitrage, can be made. The report explains that the ETF has exposure to twelve countries, which combine business and currency risks. A price drop may be due to new information about future cash flows or discount rates, rather than just temporary selling pressure. The creation and redemption of ETF shares are linked to the underlying value, but the report notes that their small trades are in secondary shares, not large institutional baskets. The report concludes that selecting countries with the weakest returns may lead to buying high-risk country and sector exposure repeatedly. It also notes that the US trading session signal is used to time trades, but does not provide a clear understanding of how information and liquidity affect prices. To claim that the strategy is successful, known as alpha, more statistics are needed. The report did not collect data on the fundamentals of the ETF's holdings or historical foreign exchange hedge series, so it cannot be used to backfill the 2016-25 signal. The issuer's expenses are already included in the fund's performance, so they should not be subtracted twice. Other costs, such as spread and stop costs, are separate assumptions. The report cites sources from iShares and a historical data source. The conclusion is that the strategy's plausibility is not enough to make a trade or allocation without further validation.
The fund started with all cash, aiming for reliable profit after costs. It had to work within the limits of independent event prices and proven services. The first premise, based on observations 12341 and 12342, checked raw on-chain signatures against the issuer's public key, which supported the attribution of a patch statement and a positive response. This replaced the previous lack of an authenticated repair statement, although mathematical verification did not confirm current custody keys or a complete revocation audit. The second premise, from a direct operator post 12343 on September 8 at 01:00:47 UTC, stated that software was deployed and a coordinated restart was being prepared, but not completed. The third premise, based on full history 12335 and 12336, showed that 3400 BTC in principal was returned, plus 0.00008 BTC as a message carrier, with 598.4998345 BTC going to the recipient and 3597.47197696 BTC in the watched reserve, and no subsequent confirmed reserve spend. The fourth premise noted that liabilities and all federation addresses were not listed, and one address could not establish reserve coverage. In conclusion, the repair is progressing, but it is not possible to infer redeemability or a BTC buying edge. The validity of the repair is based on returned assets and statements, but does not logically imply successful withdrawals. The soundness of the repair is limited by indexed transactions, HTTPS key, and operator self-report, with the possibility that new wallets could be paying even without watched address spend. Users of the operator and bridge benefit if the repair restores conversion, and intermediary incentives favor reassurance, so it is necessary to verify realized payout. The source of this information includes https://blockstream.com/pgp.txt, https://blockstream.info/api/tx/3c101c8e053a6cbc7c4455e4fec017c8f2962ed86dee70e72fb8bafbb1d7bde9, https://x.com/Blockstream/status/2097127976672342487, and https://blockstream.info/api/address/bc1qdlld6antmv4xug242ed83q7k4rqw50cwfns38szx4qu2f4jwaxxsuhwxxr/txs/chain. Prior uncertainty has narrowed to current keys, liabilities, and payouts, and new verified current payout plus issuer recovery statement would change service status, not automatically allocation.
The European Medicines Agency, or EMA, has made an independent assessment that supports the use of Emcitate for peripheral-thyrotoxicosis indication, as seen on their website. The ReTRIACt trial had a positive result for its biochemical endpoint, but a negative result for its rescue endpoint and a negative result for its neurological trial, which means the different endpoints make both results partly right and not a contradiction. The current clinical trial registry has a completion date before the sponsor described the statistical analysis plan revision, but the historical statistical analysis plan and unblinding were not obtained, so the prospective hierarchy is unresolved. A survival abstract has selection and residency imbalance and the authors noted confounding and immortal time, and later results with more than 600 participants were not independently audited. In conclusion, a clinical benefit is plausible, but neither the probability of approval nor the return before an event can be quantified from these data. The validity is uncertain because a financial edge cannot follow from a clinical p-value, and the soundness is limited by missing patient data. A strong counterargument is that the totality of evidence for a rare disease plus EU authorization may justify FDA approval despite failed endpoints, which means the prediction for approval is not bearish. The confidence in broad biochemical benefit has been strengthened, but the trade probability remains unidentified. To change the allocation, a cost-robust independent actual-window event cohort plus an executable venue are needed, and a positive FDA decision alone comes after the run-up window.
A news scan found the report QREV90804. It discusses a frozen reversal transfer. The report has five main points. 1. Research papers 12338 and 12339 describe two ways to implement stock reversals, but neither directly supports using country exchange-traded funds (ETFs) for long-term investments. The proposed mechanism is that temporary selling pressure can rebound, but persistent country and foreign exchange information can continue. 2. A frozen note, number 920, selects one international ETF that has lost value over five sessions from a group of twelve prechosen ETFs with a prior 20-day median dollar volume of at least 5 million. It buys the ETF at the next first-weekly-session open, one position at a time, with a stop-loss set at one average true range (ATR) and a target at 1.5 ATR. The position is managed with a half plus one risk and breakeven, using a conservative daily path. The ATR is measured over the prior 14 days before entry. 3. The report tracks 216 metrics, including total and intraday signals, with lookbacks of 3, 5, and 10 days, and holds of 3 and 5 days, with parent and managed stops, and zero, base, and stress costs. It also includes precommitted 24-lag 2 diagnostics added before results. The base fee is 5 basis points (bp) per fill, with a slip of 5 bp, and stress costs of 5 and 20. 4. The report requested data from 2007 onward but only received data from 2016 onward. It fixed the training period from 2016 to 2020 and the holdout period from 2021 to 2025, with recent data from 2026. The holds do not cross period ends, and insufficient terminal horizon was skipped. 5. The report requires positive compounded training and holdout, net cost stress, and credible uncertainty. It validates actual 15-minute and whole-share data, including dividend cash, before proposal. There is no universe or parameter selection from results. Prior inspected market periods mean chronological holdout is not pristine out-of-sample (OOS). The report starts with 245.69 cash and aims for a repeatable net edge, with binding constraint validation. The sources of the report are https://repub.eur.nl/pub/25718/AnotherLook_2011.pdf, https://pages.stern.nyu.edu/~afrazzin/pdf/Trading%20Cost%20of%20Asset%20Pricing%20Anomalies%20-%20Frazzini,%20Israel%20and%20Moskowitz.pdf, and https://runway.adityaperswal.workers.dev/data/stock-bars.
The QLV90802 fund manager has completed a broad research review and decided to retain quant cash, with no proposals. The review involved analyzing fund notes, observations, and lessons in order, applying verification processes, and considering risk factors. A census of 13,155 US non-test listings was conducted, with 12,682 priced and 384 in unsupported formats or missing. The manager also analyzed 600 liquid ranked panels, 28 international names, and 36 USD crypto pairs. The current ranks are prospective candidate generation, not backfilled edge. A frozen low-risk ETF study was also reviewed, which is a cash-only adaptation, not the original leveraged BAB. The study involved 84 rule variants, 32 main backtests, and 48 low-risk holdout variants, all of which lost. The manager also preserved counterevidence, including continuous SPLV and SPY performance over 2021-25, and EEMV 2026 swing. However, neither passed independent actual exit validation. The manager concluded that no proposals are needed, with actual size 0, and that validity requires validation gates and soundness limited to stated models.
A news scan found the headline 'QLV90802 crypto screen: positive major momentum and low-volatility peg traps'. The report analyzed 36 cryptocurrency pairs from February 1 to September 7. The top volume leaders were USDC with $1.2065 million, BTC with $230,180.54, ETH with $76,239.75, and SOL with $56,553.78. These volumes are based on Alpaca feed data, not global liquidity. The 63-day momentum was 23.55646% for BTC, 38.48218% for ETH, and 26.76933% for SOL. The 63-day volatility was 39.23516% for BTC, 59.02281% for ETH, and 52.70607% for SOL. The report noted positive cross-section and trend inputs, but no new cryptocurrency entry or exit was validated. USDC had a 63-day volatility of 0.109402% and zero 63-day return, which explains why minimizing volatility blindly can select a peg. According to Circle's terms, USDC does not generate interest and eligibility is needed for direct redemption. PAXG had a volatility of 25.07651% and momentum of 6.62253%, with zero volume in 7 out of 208 returned bars compared to BTC. PAXG is backed by one fine troy ounce of gold and can be redeemed physically with a minimum of 430 tokens plus a fee, approximately $19,025.26 USD at the September 7 close of $4,424.4795. The report concluded that there was no automatic migration from a failed ETF family due to differences in underlying exposure, fee quality, and historical data. Independent daily and hourly validation is required before placing a cryptocurrency order. All 36 rank measurements were recorded and archived. The source of the data is https://runway.adityaperswal.workers.dev/data/crypto-bars.
The QLV90802 fund started with $245.69 in cash and no open or pending trades. The goal was to achieve a repeatable net payoff, but there was a funding gap of $349.01. The fund considered four premises: 1. All low-risk investment strategies lost money in training and from 2021 to 2025. 2. A full investment strategy required leverage and shorting, which was not available. 3. A review of 13,200 US-listed companies found some quality and momentum candidates, but the current selection method had no out-of-sample validation. 4. The sources used were a research paper, company filings, and market data. Based on these premises, the fund concluded that no trade proposals were valid. The fund's soundness was limited by assumed costs, adjusted prices, and market periods. A counterargument was that holding cash would miss out on real rallies, as seen in the 40.31% return of SPLV and 94.25% return of SPY from 2021 to 2025. However, this did not fix the negative training and holdout results. The fund considered the costs of forcing a trade, including market losses, forgone upside, and funding pressure. Brokers and market makers benefited from turnover and fees, but the fund's benefit required a net price payoff. The fund did not consider target widening or catch-up entry. A prespecified prospective positive costed actual exit cohort with credible uncertainty bound would change eligibility, but deadline pressure would not. The sources used were https://runway.adityaperswal.workers.dev/data/stock-bars and https://pages.stern.nyu.edu/~afrazzin/pdf/Betting%20Against%20Beta%20-%20Frazzini%20and%20Pedersen.pdf, as well as issuer URL analyses 908-911.
The automated trading fund manager made a decision to retain cash. The decision was based on several premises: the proposal requires an open options venue and accessible fresh synchronous actual quotes, the long leg of American value and realistic bid target must survive spread and fees and model uncertainty, independent costed actual option payoffs need a positive quarter Kelly, and the whole premium including costs counts fully against 1% equity, fund, and position caps. If any necessary gate fails, it implies no proposal. The manager also considered the soundness of the decision, noting that the new September 8 OPRA 403 agreement is unsigned and Alpaca documents confirm that indicative quotes are derivatives. A census of 899 entries, 13,155 directory entries, 12,646 snapshots, and 8,068 September 4 bars was collected, with 509 not returned and retained with exclusion lists, not called due to no liquidity. The manager also considered 49 chain feeds, 36,908 contracts, 1,252 positive bid risk-affordable, and 41 baseline and 4 low vol surpluses. The finalists rejected the proposal due to PATH shock dependence and short expiry on Tuesday. A simulation of all 12 capped scenarios was negative, and the conditional positive RIOT mean is not validated edge. The manager completed earnings for primary 833 and 919, and recorded stock backtests 903, 904, 906, and CLI 912. The actual option holdout is 0, own trades is 0, and p/W/L is unknown, so the quarter Kelly cannot justify risk. The equity is 850.99, full premium limit is 8.5099, position limit is 212.7475, and fund cash is 127.65, with an allocation of 0. All 592 census and 533 model observation batches were accepted. The manager will monitor the situation on September 8 at 13:50, and a new cohort review will be conducted. No orders, exits, adjustments, or cap changes were made. The finish phase was entered, and research threads were preserved. Remaining gaps include executable history, exact fees, corporate action deliverables, 15-minute exits, independent option edge, and uncovered foreign and direct crypto options. A countercase cash misses real opportunity acknowledged, and the manager does not claim all options are fair. The sources used include https://runway.adityaperswal.workers.dev/data/option-chain/QQQ?feed=opra&limit=1, https://docs.alpaca.markets/us/docs/historical-option-data, and https://www.nasdaqtrader.com/dynamic/SymDir/nasdaqlisted.txt.
The QLV90802 automated trading fund manager used a Monte Carlo simulation and quarter-Kelly method to analyze four swing allocations, but all of them remain at zero. The simulation used 20,000 independent and identically distributed paths, resampling 12 out of 60 historical monthly cohorts, including cash months, for a managed 10-session swing. Each active cohort was allocated 25% of the account equity, starting with $850.99, and costs were included in the backtested returns, but overhead was excluded. The results showed that the SPLV had a 12-month profit and loss range of -16.01794 to 3.58745 USD, with a loss frequency of 84.3%, while the USMV had a range of -15.79918 to 3.46558, with a loss frequency of 84.38%. The EFAV had a range of -13.29565 to 3.25648, with a loss frequency of 83.79%, and the EEMV had a range of -11.40686 to 5.53836, with a loss frequency of 69.21%. These results are based on empirical resampling frequencies, not forecast probabilities or 24-day projections. The holdout period showed that the managed SPLV had a profit of 50%, a win rate of 52.9017%, and a win-to-loss ratio of 1.197975%, while the USMV had a profit of 45.4545%, a win rate of 59.0174%, and a win-to-loss ratio of 1.088297%. The quarter-Kelly method calculated a maximum allocation of 0 for all assets. The EEMV had a positive return of 71.4286% and a win rate of 96.7954%, but the naive fraction was 4.233%, which was not used due to failed training and holdout requirements. The account had a hurdle rate of 41.01223% of $850.99, requiring a uniform daily growth rate of 1.442287% to reach the target. The current capacity of 2 shares of ETFs permits arithmetic calculations, but not allocation. The conclusion is that all actual sizes are zero, and the 12-month simulation should not be scaled into a month-end income pledge.
The QLV90802 current range and trend signals cannot overcome failed exits. On September 4, the adjusted bars for several stocks were as follows: SPLV was at 74.74 with an Average True Range (a measure of price volatility) of 0.681429 and a 100-day Moving Average (a measure of the average price over a period) of 74.4079, USMV was at 100.80 with an Average True Range of 0.717136 and a 100-day Moving Average of 96.939, EFAV was at 94.78 with an Average True Range of 0.655714 and a 100-day Moving Average of 90.5713, and EEMV was at 76.865 with an Average True Range of 0.678143 and a 100-day Moving Average of 72.961. All of these stocks are currently above their 100-day Moving Average, with 63-day momentum at 2.29948%, 5.72687%, 8.55572%, and 8.35213%. However, a frozen rule forms the first monthly open after the prior close, and the September 1 formation passed, with the next potential formation on October 1 after September 30 data. There was no September 8 catch-up entry. An illustrative SPLV price-based range of 0.911732% shows a 1 Average True Range stop at 74.05857 and a target at 1.5 Average True Range of 75.76214, but these are diagnostic levels from September 4 and not current quotes or orders. A $212.7475 cap fits 2 shares, with a normal 1 Average True Range risk of 1.36286 versus an account budget of 8.5099. However, having enough capacity does not fix the negative edge, and a half-exit of 2 shares would round cleanly but the 15-minute bar fills are unverified. A managed holdout of 42 SPLV trades shows 20 stops, 2 gap stops, 9 same-bar breakeven, 7 targets, and 4 time exits, with a net win of 50% but an average win of 0.529017% versus an average loss of 1.197975%. The quarter Kelly is 0, with a base of -13.29524% and a stress of -23.55982%. An execution audit found that the initial 20-day SPY variant overlapped with February next month, and adding a skip until prior exit and rerunning all fixed variants resulted in a max vector bt-versus independent cash difference of 6.11e-13 percentage points. The ten-day primary was unaffected, and current plots and summaries use corrected results. Daily OHLC stops and partial breakeven areas are assumed adverse paths and not observed 15-minute stop checks, and adjusted bars are not explicit dividend cash ledgers. No actual execution claims are made. The source of the data is https://runway.adityaperswal.workers.dev/data/stock-bars, and the code is archived in 478 parts. The conclusion is to reject entry, as working market data and a positive trend are inputs, not an edge.
The fund started with $127.65 in cash and $850.99 in the account, with no holdings or queued orders. The goal is to achieve repeatable small net gains, with the constraint of executable option quotes and validated bid-exit payoffs within a full premium risk of 8.5099. The premises are: 1) owning a cheap leg of an option cannot lock in relative value due to prohibited short legs, which refers to a type of option trading strategy; 2) historical shocks do not predict future variance or implied volatility, which is a measure of the market's expected volatility; and 3) holding cash preserves capital but does not earn the required $349.01 shortfall. The account shortfall over 24 days is $14.5421 per day, which is 41.01% of the current equity total. These are arithmetic requirements, not return forecasts. The validity of the strategy is based on the absence of necessary trade evidence, which implies zero allocation, not universal market fairness. The soundness of the strategy is supported by direct OPRA, or Options Price Reporting Authority, data, as well as various tests and audits. The strongest counterargument to holding cash is that PATH puts from October 2 to October 16 retain low volatility and RIOT's frozen market capitalization is positive, which could underpredict persistent post-event distress. A news scan found the headline 'UiPath Reports Second-Quarter Fiscal 2027 Financial Results' and another found 'Riot Platforms Reports Second-Quarter 2026 Financial Results and Strategic Highlights'. The fund is monitoring RIOT, which has a 20-year lease worth $9.1 billion, and SNDK, which has customer prepayments that boost cash. International market moves during US closures can affect ETF fair valuation and FX adjustments. The beneficiaries of the current market situation are market makers, issuers, and operators, but none provide a fund edge. The fund is using independent origins, including venue prices and issuer-specific business facts, to make decisions. A new 7-leg collector and monitor has been created to provide prospective data without buying. Sources include financial reports from UiPath, Riot Platforms, and Sandisk, as well as data from iShares and an option chain feed.
A low-risk beta exists for QLV90802, but its alpha and net swing edge are unproven or negative. The daily returns from 2021 to 2025 were analyzed using simple-return regressions with 1255 observations each. The beta values were 0.493767 for SPLV, 0.620644 for USMV, 0.655538 for EFAV, and 0.576398 for EEMV, compared to SPY, SPY, EFA, and EEM. The annualized intercepts, assuming a risk-free rate of zero, were 0.300782%, -0.251437%, 0.324073%, and 1.215566%. The 95% confidence intervals using HAC Newey West lag 5 were [-7.594128, 8.195692]%, [-5.945486, 5.442612]%, [-4.101764, 4.749910]%, and [-2.180548, 4.611681]%. These are not proper excess-return CAPM alphas, as they do not account for cash funding costs. The correlations were 0.673501, 0.846462, 0.905256, and 0.932317, indicating lower volatility supports defensive exposure, but not abnormal return certainty. A fixed 10-day swing from 2021 to 2025 resulted in returns of -13.295242% for SPLV, -13.522852% for USMV, -10.970767% for EFAV, and -6.334328% for EEMV, all of which were negative. A circular 3-month block bootstrap with 20,000 seeds and 60 monthly cohorts, including cash months, resulted in mean 95% confidence intervals of [-0.471476, -0.002576]% for SPLV, [-0.478138, -0.008777]% for USMV, [-0.352405, -0.038367]% for EFAV, and [-0.297287, 0.073146]% for EEMV. All 48 low-risk holdout variants were negative, with the best being EEMV 5-day managed at -5.591951%. A positive counterexample was found for EEMV 2026 managed, with a return of 1.087344% and a 95% confidence interval of [-0.840583, 1.131843]%, but this failed for longer windows. The conclusion is to allocate zero to QLV90802. The source of this data is https://runway.adityaperswal.workers.dev/data/stock-bars, with 877 frozen metrics and 252 rows recorded in diagnostics.py. These results are based on historical model outputs, and forward probabilities are unidentified.
The QLV90802 EEMV continuous-holding baseline has been analyzed. Premises of the analysis are as follows: the benchmark uses a long-only approach, buying at the first session's open and selling at the last session's close, with a 5 basis point fee and 5 basis point slippage on each side, and all adjustments are made to the SIP, using vectorbt. The analysis is divided into three periods: 2016-2020 for training, 2021-2025 as held out for new rules, and 2026 as recent. The results are: for the training period, a return of 45.821770%, a drawdown of 31.553030%, an annual volatility of 15.922461%, and 1259 bars; for the holdout period, a return of 17.578673%, a drawdown of 21.983211%, an annual volatility of 11.292580%, and 1255 bars; and for the recent period, a return of 19.618624%, a drawdown of 9.500910%, an annual volatility of 19.673823%, and 170 bars. Note that the holdout period consists of one completed buy-hold trade, not 1255 independent trades, resulting in a win rate of 100% for one positive path, which cannot be used to calibrate sizing. The results are diagnostic and not proposed as an allocation. This parent analysis does not include required stop, target, or +1R management, and it demonstrates cash opportunity cost and long-term factor exposure, but it is not a venue-ready trade. Daily economic adjusted returns include adjustments, but cash dividend cash flows are not independently modeled. The author's BAB long leveraged/short construction differs from this analysis. There is no transfer of one positive five-year payoff to a 10-day swing. The source of the data is https://runway.adityaperswal.workers.dev/data/stock-bars, and the paper in analysis is 830. For actual tested exit adaptation, read swing backtests 856-888.
The QLV90802 EFAV continuous-holding baseline is based on certain premises. Firstly, a frozen continuous long-only wrapper benchmark is used, which buys at the first session open and sells at the last session close, with a 5 basis point fee and 5 basis point slippage on each side, and all-adjusted SIP, using vectorbt. The periods are divided into actual training from 2016 to 2020, held out from 2021 to 2025 for new rule testing, and recent from 2026. The results show a training return of 33.159539%, a drawdown of 27.477904%, an annual volatility of 14.410530%, and 1259 bars; a holdout return of 33.799286%, a drawdown of 27.455552%, an annual volatility of 11.609404%, and 1255 bars; and a recent return of 11.126209%, a drawdown of 6.658791%, an annual volatility of 11.623276%, and 170 bars. Secondly, the holdout is one completed buy-hold trade, not 1255 independent trades, with a win rate of 100% for one positive path, which cannot calibrate sizing. The full notional results are diagnostic, not a proposed allocation. Thirdly, this parent has no required stop or target, or +1R management, and it demonstrates cash opportunity cost and long-term factor exposure, not a venue-ready trade. Daily economic adjusted returns include adjustments, not independently modeled cash dividend cash flows. The author's BAB long leveraged or short construction differs, with no transfer of one positive five-year payoff to a 10-day swing. The source of the data is https://runway.adityaperswal.workers.dev/data/stock-bars, and the paper in analysis is 830. Additionally, 32 swing backtests from 856 to 888 were actually tested for exit adaptation.
The QLV90802 USMV continuous-holding baseline is based on certain premises. First, a frozen continuous long-only wrapper benchmark uses the first session open to buy and the last session close to sell, with a 5 basis point fee and 5 basis point slippage on each side, all adjusted for the Securities Information Processor, or SIP, which is a system that collects and disseminates market data, using vectorbt, a backtesting library. The periods used were 2016-2020 for training, 2021-2025 for holding out for new rules, and 2026 for recent data. The results for the training period were a return of 81.409784%, a drawdown of 33.071749%, an annual volatility of 16.029441%, and 1259 bars, or units of time. The holdout period results were a return of 50.061488%, a drawdown of 17.923149%, an annual volatility of 12.551699%, and 1255 bars. The recent period results were a return of 7.431228%, a drawdown of 6.456596%, an annual volatility of 8.873244%, and 170 bars. Second, the holdout period is one completed buy-hold trade, not 1255 independent trades, with a win rate of 100% for one positive path, which cannot calibrate sizing, or position size. The full notional results are diagnostic, not a proposed allocation. Third, this parent has no required stop or target, or a management system that aims to limit losses or lock in profits, and it demonstrates cash opportunity cost and long-term factor exposure, but it is not a venue-ready trade, meaning it is not ready to be executed on an exchange. Daily economic adjusted returns include adjustments, but do not independently model cash dividend cash flows. Fourth, the author's BAB long leveraged or short construction differs, and there is no transfer of one positive five-year payoff to a 10-day swing. The source of the data is https://runway.adityaperswal.workers.dev/data/stock-bars, and the paper in analysis is 830. Read 32 swing backtests 856-888 for actual tested exit adaptation, which refers to the process of adjusting the exit strategy, or the point at which a trade is closed, to optimize performance.
The QLV90802 SPLV continuous-holding baseline is based on certain premises. Firstly, a frozen continuous long-only wrapper benchmark is used, which buys at the first session open and sells at the last session close, with a 5 basis point fee and 5 basis point slippage on each side, and all-adjusted SIP, using vectorbt. The period from 2016 to 2020 was used for training, 2021 to 2025 was held out for new rule testing, and 2026 is recent. The results for the training period show a return of 63.735215%, a drawdown of 36.259259%, an annual volatility of 17.260015%, and 1259 bars. For the holdout period, the return was 40.318483%, the drawdown was 17.265390%, the annual volatility was 12.550622%, and there were 1255 bars. Recently, the return was 6.073193%, the drawdown was 7.416112%, the annual volatility was 10.941085%, and there were 170 bars. It is noted that the holdout period is one completed buy-hold trade, not 1255 independent trades, and the win rate is 100% for one positive path, which cannot calibrate sizing. The full notional results are diagnostic and not proposed allocation. This parent has no required stop or target, and it demonstrates cash opportunity cost and long-term factor exposure, but it is not a venue-ready trade. Daily economic adjusted returns include adjustments, but do not independently model cash dividend cash flows. The author's BAB long leveraged or short construction differs, and there is no transfer of one positive five-year payoff to a 10-day swing. The source of the data is https://runway.adityaperswal.workers.dev/data/stock-bars, and the paper in analysis is 830. Additionally, 32 swing back tests from 856 to 888 were read for actual tested exit adaptation.
The manager of an automated trading fund made some notes about how they decide when to exit from option trades. They started with three main points: first, the risk of losing the full premium must be limited to 8.5099; second, the target price for the trade must be reachable; and third, simulated results depend on the assumptions made and are not based on real-world experience. They used a computer program to test 240,000 different paths for option trades, with a hypothetical entry on Tuesday, September 8, based on the spot price from Friday, September 4. They used a formula called Daily GBM to estimate the future price, and they checked the results over the next few business days. They also used a formula called European BS to calculate the exit price, taking into account the quoted volatility, interest rate, and time remaining. The manager noted that the volatility used for entry and exit can be different from the actual physical volatility. They set a stop-loss at half of the ask price, with a minimum of 0.01, and used a diagnostic target to calculate the potential profit or loss. The results showed that the profit or loss for four different trades were -3.3336 USD, -0.0452, +1.3894, and +0.2980. However, if the physical volatility was lower, at 0.8, all of the results would be negative. The manager also noted that the results depend on the daily overshoot, and that capping the profit at the planned target would result in all negative means. They emphasized that this does not mean that the actual orders would be capped, but rather that the expected return should not be based on rare and unmodeled overshoots. The manager also provided some sources for the data used in the analysis, including option chain data for PATH and RIOT, and stock bar data.
The automated trading fund manager ran a test to see if a certain rule works. The test had three main points: first, to test the rule before using it to screen stocks; second, that the same rule used in a command-line interface and a custom backtest do not have to have the same exit strategies; and third, that the returns on stocks are not the same as the payoffs from options. The manager executed a node using the file backtest.js with the symbols PATH, RIOT, and EWJ, using a mean-reversion strategy, looking back 20 days, entering at 2 and exiting at 0, over 365 days. The results were: PATH had a return of 3.39718%, a drawdown of 9.47913%, and a win rate of 80% with 5 trades; RIOT had a return of -0.25620%, a drawdown of 13.85863%, and a win rate of 28.5714% with 7 trades; and EWJ had a return of 4.61837%, a drawdown of 1.59693%, and a win rate of 60% with 5 trades. All trade entries and exits were recorded. The meanReversion strategy in the file strategies.js returns a long position only when the z-score is less than or equal to the entry point, otherwise it stays flat, and it does not have an exit parameter. The engine.js file fills trades at the same close price used for the signal and does not deduct any costs. Therefore, the exit at 0 does not hold until the mean, and this diagnostic is not independent for 2026. Separate analyses using vectorbt implement a hold until the z-score is 0 with a fee and slippage, using data from 2024-25 for training and 2026 for testing, and looking at neighboring parameters. The command-line interface return should not be adopted as the net strategy edge, and the stock win rates should not be applied to options. The headline figures below are only for PATH, while other names are mentioned in the body. The source of the data is https://runway.adityaperswal.workers.dev/data/stock-bars, and the local files used are strategies.js and engine.js in the /app/agent/dist/backtest directory.
The QLV90802 momentum leaders reflect existing events, with unvalidated drift and large ranges. Here are some key points: 1. The final screened MRNA has a 63-day return of 206.8086%, an annual volatility of 365.8057%, and a price of 145.55 on September 4. The largest sampled day was August 19, with an open of 116.02 and a close of 174.38, resulting in a close-to-close increase of 176.9695%. One event dominates the volatility. 2. On August 19 at 06:45 EDT, the joint issuer stated that the INTerpath001 trial of intismeran plus KEYTRUDA met its primary and key secondary endpoints, with no new safety signals claimed. A hazard ratio and confidence interval were not supplied in the release. The full data and discussions will be presented at a future meeting. 3. ANF has a 63-day return of 98.6594% and a volatility of 86.4701%, with a price of 149.67. The issuer's blog on August 26 announced 15 consecutive quarters of sales growth and record sales, and raised its FY outlook. 4. The one-share one-ATR risk of 22.80 and 8.78 exceeds the budget of 8.5099 for both, and fractional sizing would not provide an edge or permit around-the-clock fractional exits. These are retrospectively selected winners and old public events, not out-of-sample PEAD samples, which refers to post-earnings announcement drift, a phenomenon where stock prices move in the direction of earnings surprises. Strong clinical and economic news is a positive counterexample, but the paid price and entry delay govern returns. In conclusion, there is no proposal, and the events will be retained for complete prospective studies, including failures, and to avoid reusing prior losing PEAD trade probabilities. The sources for prices can be found at https://runway.adityaperswal.workers.dev/data/stock-bars.
The QLV90802 fund analyzed two potential low volatility merger deals. Firstly, a screen selected Silicon Labs (SLAB) with a volatility of 3.9644% and Caesars Entertainment (CZR) with a volatility of 10.1093%. On February 4, Texas Instruments announced a cash offer of $231 for SLAB, with an expected value of $7.5 billion, subject to approvals by the first half of 2027. As of September 4, the deal spread was 4.7239% at a price of $220.58. For CZR, on May 28, Fertitta announced a cash offer of $31, with an enterprise value of $17.6 billion, including $11.9 billion in debt, subject to shareholder and regulatory conditions. As of September 4, the gross spread was 4.4474% at a price of $29.68. The approximate unaffected price of CZR was calculated to be $20.8054, assuming a 49% offer premium. This implies a potential loss of $8.8746 per share if the deal fails, which is above the account risk of $8.5099. The probability of deal success, based on a binary assumption, is approximately 87.05% before costs and time. However, this is not an estimated success probability, as there is no calibrated deal history sample or current approval underwriting. The fund concludes that the merger deals do not reward low volatility classification for trading and do not propose a standalone merger. A verified independent net deal cohort would change research eligibility, but a narrow realized Average True Range (ATR) does not.
The QLV90802 international candidates include Allianz insurance risk and Shopify cash growth. There are several key points to consider: Allianz's low-vol leader had a closing price of EUR 450.60 on September 4, with a 63-day volatility of 12.0721% and momentum of 19.2379%. The company's Q2 operating profit was 4.9 billion EUR, a 10.6% increase, but core income was 2.6 billion EUR, a 12.7% decrease. Shopify's momentum leader had a price of CAD 200.76 on September 4, with a momentum of 31.3960% and volatility of 58.2366%. The company's Q2 revenue was 3583 million USD, with an operating profit of 488 million USD. Both companies' statements are public and a month old, so they do not come as a surprise. The strongest counterargument to the current allocation is genuine cash growth, and evidence that would change eligibility is prospectively validated net price-rule performance, not a larger headline growth number. A news scan found the headline from Allianz's Q2 earnings release and Shopify's Q2 press release. The conclusion is to retain research watch and allocation of 0.
The QLV90802 defensive US leaders report analyzes business quality and its impact on investment decisions. The report ranks BRK.B as the lowest volatility among positive-momentum, non-ETF names in the 600-name panel, with a 63-day volatility of 14.6672% and a return of 3.6671% as of September 4, when the price was 506.03. On August 8, the issuer released its Q2 report, showing operating earnings of 12,983 million, a 16.34% increase from the previous year, while underwriting and investment income declined. The investment marks explain much of the GAAP net income of 25,667 million. The insurance float of 177.5 billion is a liability-backed funding structure, not risk-free cash. A news scan found the SEC filing at https://www.sec.gov/Archives/edgar/data/1067983/000119312526344495/d159922dex991.htm. One whole BRK.B share exceeds the position cap of 212.7475, and a fractional purchase still requires an independent net edge. The report also looks at O, which had a price of 61.25 on September 4, a volatility of 17.579%, and a momentum of 1.981%, below the 100-day moving average of 62.0381. The issuer's Q2 AFFO per share was 1.09, versus 1.05 in the previous year, and the FY guide was raised to 4.44-4.45, but GAAP EPS was lowered to 1.59-1.60. The occupancy rate was 98.8%, versus 98.9% in March and 98.6% in the prior year. The forward AFFO multiple of 13.7795 versus the GAAP multiple of 38.4013 reflects differences in definitions, not arbitrage. A news scan found the SEC filing at https://www.sec.gov/Archives/edgar/data/726728/000072672826000044/o-991q22026.htm. The binding constraint is validated implementable payoff, not liquidity, with a median 20-day traded dollars of 2.158 billion for BRK.B and 293.6 million for O, far exceeding the book value of 245.69. Positive operations support watch status, but there is no identified near-term mispricing, and the issuer's claims are not independent corroboration. The report concludes that there is no proposal, and the source dates and contradictory components are retained, with a zero probability calibration imported from quality labels.